| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 57 |
| 1 | ISOTRETINOIN | 48 |
| 2 | LENALIDOMIDE | 48 |
| 3 | VEDOLIZUMAB | 31 |
| 4 | RIBAVIRIN | 28 |
| 5 | SODIUM OXYBATE | 26 |
| 6 | ACETAMINOPHEN | 20 |
| 7 | CELECOXIB | 17 |
| 8 | USTEKINUMAB | 17 |
| 9 | ALEMTUZUMAB | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISATUXIMAB-IRFC | 1 | 0.0185 |
| 1 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 2 | 0.0056 |
| 2 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 2 | 0.0051 |
| 3 | ACITRETIN | 12 | 0.0024 |
| 4 | DEXTROMETHORPHAN HBR, GUAIFENESIN | 2 | 0.0020 |
| 5 | TERCONAZOLE | 1 | 0.0012 |
| 6 | VELAGLUCERASE ALFA | 2 | 0.0010 |
| 7 | ISOTRETINOIN | 48 | 0.0010 |
| 8 | PONATINIB HYDROCHLORIDE | 5 | 0.0010 |
| 9 | MECHLORETHAMINE HYDROCHLORIDE | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 99 |
| 1 | Retinoid [EPC] | 60 |
| 2 | Thalidomide Analog [EPC] | 49 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 43 |
| 4 | Corticosteroid [EPC] | 40 |
| 5 | Integrin Receptor Antagonist [EPC] | 33 |
| 6 | Interferon alpha [EPC] | 32 |
| 7 | Nucleoside Analog Antiviral [EPC] | 28 |
| 8 | Atypical Antipsychotic [EPC] | 20 |
| 9 | Interleukin-23 Antagonist [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 16 | 0.0008 |
| 1 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 2 | Phenylalanine Metabolizing Enzyme [EPC] | 5 | 0.0006 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 8 | Integrin Receptor Antagonist [EPC] | 33 | 0.0004 |
| 9 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |